Michael Linn

This inventor holds 13 USPTO granted patents and 20 published patent applications and 19 EPO patents. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2021-2026.

USPTO Granted Patents = 13 (Patent Applications = 20)

% Patents Active = 100.0

EPO Patents = 19 (Patent Applications = 36)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Waldbockelheim, DE (2023)
Waldboeckelheim, DE (2021 - 2024)
Waldböckelheim, DE (2022 - 2024)

Company Filing History:

13 out of 333

Lts Lohmann Therapie-Systeme Ag

patents

Years Active: 2021-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12667540 - Rolled oral thin films having a high level of active-ingredient loading (2026-06-30),

2. 12661314 - Multi-layer oral thin film (2026-06-23),

3. 12629333 - Oral thin film (2026-05-19),

4. 12527751 - Oral thin film with high active agent loading (2026-01-20),

5. 12054335 - Device and method for dispensing active ingredient-containing or active ingredient-carrying strips (2024-08-06),

6. 11992561 - Oral thin film of polyvinyl alcohol and polyvinyl alcohol-polyethylene glycol graft copolymer (2024-05-28),

7. 11744806 - Frigostable composition for iontophoretic transdermal delivery of a triptan compound (2023-09-05),

8. 11634268 - Device and method for dispensing active ingredient-containing or active ingredient-carrying strips (2023-04-25),

9. 11547677 - Transmucosal delivery system for idebenone (2023-01-10),

10. 11464760 - Frigostable composition for iontophoretic transdermal delivery of a triptan compound (2022-10-11),

11. 11304912 - Transdermal therapeutic system on the basis of adhesive plasticizer-polymer matrices (2022-04-19),

12. 11213491 - Film-like form of administration for the transmucosal delivery of antidiabetic peptides (2022-01-04),

13. 10926941 - Device and method for dispensing active ingredient-containing or active ingredient-carrying strips (2021-02-23),

Title: Michael Linn: Innovator in Oral Thin Film Technology

Introduction

Michael Linn is a notable inventor based in Waldböckelheim, Germany. He has made significant contributions to the field of oral thin film technology, holding a total of 13 patents. His work focuses on developing innovative methods for producing effective oral drug delivery systems.

Latest Patents

Among his latest patents, Linn has developed a method for producing rolled oral thin films with a high level of active-ingredient loading. This invention involves creating a water-erodible, water-soluble, or water-dispersible active-ingredient-administering form. The process includes producing a film that contains the active ingredient, activating its surface to generate a tacky texture, and rolling it up to form a stable laminate. These laminates are designed to be easily dispensed and cut, making them suitable for administering larger amounts of active ingredients compared to conventional oral thin film products. Another significant patent is for a multi-layer oral thin film, which consists of at least two layers of water-soluble polymers connected by selective sealing. This innovation enhances the film's effectiveness as a medicament.

Career Highlights

Michael Linn has worked with prominent companies in the pharmaceutical industry, including LTS Lohmann Therapie-Systeme AG and Santhera Pharmaceuticals AG. His experience in these organizations has contributed to his expertise in developing advanced oral drug delivery systems.

Collaborations

Throughout his career, Linn has collaborated with notable professionals in the field, including Markus Müller and Christoph Schmitz. These partnerships have fostered innovation and the advancement of oral thin film technologies.

Conclusion

Michael Linn's contributions to oral thin film technology have significantly impacted the pharmaceutical industry. His innovative patents and collaborations highlight his dedication to improving drug delivery methods.